View Author
patient heart plaque -15 study abstr suppl gdf -15 levels gdf -15 disease factor death level infarction mortality trial circulation event artery syndrome failure cardiology outcome artery disease university follow-up aortic nste-ac heart failure signi prognostic imaging therapy result value risk factors hospital medicine blood atherosclerosi marker group cohort table end point effect point center treatment prognostic information registry valve stent stenosi research month swets subscription service session signi ficantly derivation cohort ischemia difference ͻ0.001 admission thrombosis department atrial fi brillation european society atherosclerotic technique vulnerability randomized <0.001 lesion figure scienti prevention ablation ficant study end point
5 Most Recent Publications
|
Highlights of the 2008 Scientific Sessions of the European Society of Cardiology. Munich, Germany, August 30 to September 3, 2008
(Article)
Kristensen, S.D. Baumgartner, H. Schunkert, H. Vardas, P.E. Wall, E.E. van der Bax, J.J. Casadei, B. Drexler, H. Eeckhout, E. Filippatos, G.S. Fox, K.A.A. Perk, J. Piérard, L. Poldermans, D. |
2008-12-09
|
|
Highlights of the 2007 Scientific Sessions of the European Society of Cardiology. Vienna, Austria, September 1-5, 2007
(Article)
Kristensen, S.D. Baumgartner, H. Sipido, K.R. Wall, E.E. van der Fox, K.M. Bax, J.J. Drexler, H. Eeckhout, E. Filippatos, G.S. Gitt, A.K. Linde, C. Piérard, L. Poldermans, D. Schunkert, H. |
2007-12-18
|
|
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome
(Article)
Wollert, K.C. Kempf, T. Armstrong, P.W. Califf, R.M. Drexler, H. Wallentin, L.C. Peter, T. Olofsson, S. James, S.K. Johnston, N. Lindahl, B. Horn-Wichmann, R. Brabant, G. Simoons, M.L. |
2007-02-01
|
|
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
(Article)
Naghavi, M. Libby, P. Fayad, Z. Stone, P.H. Waxman, S. Raggi, P. Madjid, M. Zarrabi, A. Burke, A.E. Yuan, C. Fitzgerald, P.J. Siscovick, D.S. Falk, E. Korte, C.L. de Aikawa, M. Juhani Airaksinen, K.E. Assmann, G. Becker, C.R. Chesebro, J.H. Farb, A. Galis, Z.S. Jackson, C. Jang, I.K. Casscells, S.W. Koenig, W. Lodder, R.A. March, K. Demirovic, J. Navab, M. Priori, S.G. Rekhter, M.D. Bahr, R. Grundy, S.M. Mehran, R. Litovsky, S. Colombo, A. Boerwinkle, E. Ballantyne, C. Insull Jr, W. Schwartz, R.S. Vogel, R. Serruys, P.W.J.C. Hansson, G.K. Faxon, D.P. Kaul, S. Rumberger, J. Drexler, H. Greenland, P. Muller, J.E. Virmani, R. Ridker, P.M. Zipes, D.P. Shah, P.K. Willerson, J.T. Badimon, J.J. Stefanadis, C. Moreno, P.R. Pasterkamp, G. |
2003-10-14
|
|
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.
(Article)
Naghavi, M. Libby, P. Fayad, Z. Stone, P.H. Waxman, S. Raggi, P. Madjid, M. Zarrabi, A. Burke, A.E. Yuan, C. Fitzgerald, P.J. Siscovick, D.S. Falk, E. Korte, C.L. de Aikawa, M. Juhani Airaksinen, K.E. Assmann, G. Becker, C.R. Chesebro, J.H. Farb, A. Galis, Z.S. Jackson, C. Jang, I.K. Casscells, S.W. Koenig, W. Lodder, R.A. March, K. Demirovic, J. Navab, M. Priori, S.G. Rekhter, M.D. Bahr, R. Grundy, S.M. Mehran, R. Litovsky, S. Colombo, A. Boerwinkle, E. Ballantyne, C. Insull Jr, W. Schwartz, R.S. Vogel, R. Serruys, P.W.J.C. Hansson, G.K. Faxon, D.P. Kaul, S. Rumberger, J. Drexler, H. Greenland, P. Muller, J.E. Virmani, R. Ridker, P.M. Zipes, D.P. Shah, P.K. Willerson, J.T. Badimon, J.J. Stefanadis, C. Moreno, P.R. Pasterkamp, G. |
2003-10-07
|
